Australia markets closed

Hyphens Pharma International Limited (1J5.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.29000.0000 (0.00%)
At close: 10:49AM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
156,323
162,316
125,883
120,977
119,442
Cost of revenue
96,572
99,507
77,800
77,341
76,773
Gross profit
59,751
62,809
48,083
43,636
42,669
Operating expenses
Selling general and administrative
48,422
47,828
40,033
36,661
34,609
Total operating expenses
47,930
47,336
39,602
34,597
34,220
Operating income or loss
11,821
15,473
8,481
9,039
8,449
Interest expense
327
238
95
110
138
Income before tax
10,647
14,291
8,256
7,108
7,987
Income tax expense
1,954
2,882
1,410
945
1,457
Income from continuing operations
8,693
11,409
6,846
6,163
6,530
Net income
8,757
11,351
6,846
6,163
6,530
Net income available to common shareholders
8,757
11,351
6,846
6,163
6,530
Basic EPS
0.03
0.04
0.02
0.02
0.02
Diluted EPS
0.03
0.04
0.02
0.02
0.02
Basic average shares
309,856
308,776
301,070
300,430
300,271
Diluted average shares
310,567
310,261
302,238
300,430
300,271